[Time dependence of myocardial preservation after thrombolysis. Consequences for indication and procedure]

Area of Science:

• Cardiology
• Pharmacology
• Biomedical Engineering

Context:

• Acute myocardial infarction poses a significant threat to left ventricular function.
• Effective thrombolytic therapy aims to limit infarct size and preserve cardiac muscle.
• The time-dependent nature of treatment efficacy is crucial for patient outcomes.

Purpose:

• To investigate the time-dependent relationship between symptom onset and intracoronary streptokinase infusion on infarct size.
• To evaluate the efficacy of intravenous urokinase as a simplified thrombolytic strategy.
• To determine the optimal time window for initiating thrombolytic therapy to limit myocardial damage.

Summary:

• A significant correlation exists between early intervention (within 2 hours) and preserved left ventricular wall motion.
• Intracoronary thrombolytic therapy initiated later than 2 hours resulted in less than 50% probability of wall motion improvement.
• Intravenous urokinase demonstrated 60% coronary patency within one hour, showing clinical relevance in limiting infarct size when administered early.

Impact:

• Early thrombolytic therapy, particularly within 2 hours of symptom onset, is indicated for all acute myocardial infarction patients.
• Intravenous urokinase presents a simpler and effective alternative to streptokinase for acute myocardial infarction treatment.
• Preserving left ventricular function through timely intervention significantly improves long-term prognosis for heart attack survivors.